News

An experimental cancer, lung disease and Alzheimer's drug may slow the progression of atherosclerosis that leads to heart disease, a new study shows.

Researchers have identified a previously unknown weak spot in prostate cancer cells that could also lead to entirely new therapeutic approaches for other types of cancer.

New research has identified that circular RNAs – a recently discovered family of gene fragments – can stick to cellular DNA and cause mutations that result in cancer.

The study's findings may be applied in the future to significantly improve the effectiveness and applicability of cancer immunotherapy.

The paper is one of the first to uncover the "genetic travelogue" of a cancer that evolves across multiple different tissues.

In a study of 51,258 survivors weighted to represent a larger population of approximately 178.8 million people, 3.6 million survivors reported a functional limitation in 1999, and that number increased to 8.2 million in 2018.

New research has uncovered an unexpected link between two hallmarks of cancer: chromosomal instability and epigenetic alterations.

Not all cancer metastases have the same destructive effect. Researchers demonstrate different mechanisms in experiments.

Zirconium-based materials have been shown to effectively separate radium and actinium, which could enable the large-scale production of radioisotopes for cancer therapy.

Results of a large Phase 3 clinical trial reveal that a targeted cancer drug, osimertinib, cut the risk of death by 51% for patients following surgery to remove non-small cell lung cancers harboring a specific mutation.